Researchers devised a way to miniaturize cell production for cancer treatment. The method for producing CAR-T cells, developed at the Singapore-MIT Alliance for Research and Technology, uses fewer resources and a smaller footprint than existing automated manufacturing platforms and could lead to more affordable methods of cell therapy manufacturing.

Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP), an Interdisciplinary Research Group (IRG) at the Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, have identified a critical quality attribute (CQA) for the possible development of a rapid and sensitive process analytical technology (PAT) for sterility. Specifically, this technology…

Researchers from Critical Analytics for Manufacturing Personalized-Medicine (CAMP) Interdisciplinary Research Group (IRG) at Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, in collaboration with Singapore Centre for Environmental Life Sciences Engineering (SCELSE) and Massachusetts Institute of Technology (MIT), have developed a novel method capable of identifying…

MIT SMART researchers have developed a novel method to enhance the ability of mesenchymal stromal cells (MSCs) to generate cartilage tissue by adding ascorbic acid during MSC expansion.

Stacy Springs has been named executive director and Richard Braatz is the new associate faculty director at MIT's Center for Biomedical Innovation.

A tiny microfluidic device can improve cell therapy techniques for spinal cord injury patients. The device can remove a large percentage of stem cells that have not yet fully become spinal cord cells, which could potentially form tumors after being transplanted into a patient.